<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">19426754</PMID>
        <DateCompleted>
            <Year>2009</Year>
            <Month>08</Month>
            <Day>28</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>01</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-5177</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>93</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2009</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Pharmacology, biochemistry, and behavior</Title>
                <ISOAbbreviation>Pharmacol Biochem Behav</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44.</ArticleTitle>
            <Pagination>
                <MedlinePgn>141-7</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pbb.2009.04.022</ELocationID>
            <Abstract>
                <AbstractText>Prepulse inhibition of startle (PPI) is an operational measure of sensorimotor gating that is impaired in schizophrenia. Treatment with mixed dopamine D2/D3 antagonists diminishes schizophrenia symptoms, and opposes dopamine agonist-induced PPI deficits in rats. There are reasons to believe that functional D3 receptor antagonists might offer more favorable therapeutic profiles compared to current antipsychotics. However, D3-related drug discovery is hampered by the absence of assays sensitive to D3-mediated (antipsychotic) properties in vivo. Here, we characterized two putative D3-active compounds - WC10 and WC44 - in a PPI-based screening assay, comparing the sensitivity of test compounds to oppose PPI deficits induced by the mixed D1/D2-like agonist apomorphine vs. the preferential D3 agonist pramipexole in rats. WC10, WC44 (0, 1, 3, 10 mg/kg, each), and the preferential D2 antagonist L741,626 (0, 1 mg/kg) were studied, in combination with apomorphine (0, 0.5 mg/kg), or pramipexole (0, 1 mg/kg). L741,626 prevented apomorphine-, but not pramipexole-induced PPI deficits. WC10, but not WC44, prevented apomorphine-induced PPI deficits; both compounds opposed pramipexole-induced PPI deficits, suggesting functional D3 and D1/D2 antagonist profiles for WC10, and functional D3 receptor antagonism for WC44. This assay may be valuable for detecting predominantly D3 vs. D2 receptor-linked mechanisms of action in vivo.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Weber</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, UCSD School of Medicine, La Jolla, CA 92037-0804, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chang</LastName>
                    <ForeName>Wei-Li</ForeName>
                    <Initials>WL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Durbin</LastName>
                    <ForeName>John P</ForeName>
                    <Initials>JP</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Paula E</ForeName>
                    <Initials>PE</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Luedtke</LastName>
                    <ForeName>Robert R</ForeName>
                    <Initials>RR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mach</LastName>
                    <ForeName>Robert H</ForeName>
                    <Initials>RH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Swerdlow</LastName>
                    <ForeName>Neal R</ForeName>
                    <Initials>NR</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 MH068366-05A2</GrantID>
                    <Acronym>MH</Acronym>
                    <Agency>NIMH NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>MH59803</GrantID>
                    <Acronym>MH</Acronym>
                    <Agency>NIMH NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>DA23957</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 MH068366</GrantID>
                    <Acronym>MH</Acronym>
                    <Agency>NIMH NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 DA023957-02</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 DA023957</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 MH059803-10</GrantID>
                    <Acronym>MH</Acronym>
                    <Agency>NIMH NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>MH68366</GrantID>
                    <Acronym>MH</Acronym>
                    <Agency>NIMH NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 MH059803</GrantID>
                    <Acronym>MH</Acronym>
                    <Agency>NIMH NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2009</Year>
                <Month>05</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Pharmacol Biochem Behav</MedlineTA>
            <NlmUniqueID>0367050</NlmUniqueID>
            <ISSNLinking>0091-3057</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D052160">Benzothiazoles</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018492">Dopamine Antagonists</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D065127">Dopamine D2 Receptor Antagonists</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D007211">Indoles</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010879">Piperazines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010880">Piperidines</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D017448">Receptors, Dopamine D2</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D050637">Receptors, Dopamine D3</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C543148">WC10 compound</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C543147">WC44 compound</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>81226-60-0</RegistryNumber>
                <NameOfSubstance UI="C104750">3-(4-(4-chlorophenyl-4-hydroxypiperidino)methyl)indole</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>83619PEU5T</RegistryNumber>
                <NameOfSubstance UI="D000077487">Pramipexole</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>N21FAR7B4S</RegistryNumber>
                <NameOfSubstance UI="D001058">Apomorphine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014150" MajorTopicYN="Y">Antipsychotic Agents</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001058" MajorTopicYN="N">Apomorphine</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D052160" MajorTopicYN="N">Benzothiazoles</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018491" MajorTopicYN="N">Dopamine Agonists</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018492" MajorTopicYN="N">Dopamine Antagonists</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D065127" MajorTopicYN="N">Dopamine D2 Receptor Antagonists</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010880" MajorTopicYN="N">Piperidines</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000077487" MajorTopicYN="N">Pramipexole</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017448" MajorTopicYN="N">Receptors, Dopamine D2</DescriptorName>
                <QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D050637" MajorTopicYN="N">Receptors, Dopamine D3</DescriptorName>
                <QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName>
                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013216" MajorTopicYN="N">Reflex, Startle</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2009</Year>
                <Month>03</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2009</Year>
                <Month>04</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2009</Year>
                <Month>04</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2009</Year>
                <Month>5</Month>
                <Day>12</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2009</Year>
                <Month>5</Month>
                <Day>12</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2009</Year>
                <Month>8</Month>
                <Day>29</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">19426754</ArticleId>
            <ArticleId IdType="pii">S0091-3057(09)00141-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.pbb.2009.04.022</ArticleId>
            <ArticleId IdType="pmc">PMC2720754</ArticleId>
            <ArticleId IdType="mid">NIHMS127825</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Biol Psychiatry. 1986 Jan;21(1):23-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3080033</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychopharmacology (Berl). 1988;94(4):507-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3131796</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1990 Sep 13;347(6289):146-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1975644</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>C R Acad Sci III. 1990;311(13):501-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2129115</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Exp Ther. 1992 Nov;263(2):486-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1432685</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Gen Psychiatry. 1994 Feb;51(2):139-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8297213</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Pharmacol. 1994 Oct 3;263(3):235-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7843260</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuropsychopharmacology. 1995 Apr;12(2):139-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7779242</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Pharmacol. 1996 Sep 19;312(1):35-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8891576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Gen Psychiatry. 1997 Mar;54(3):225-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9075463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Behav Pharmacol. 1998 Sep;9(5-6):389-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9832924</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Behav Pharmacol. 1998 Sep;9(5-6):445-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9832930</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 1999 Jun 1;19(11):4627-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10341260</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Discov Today. 2005 Jul 1;10(13):917-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15993811</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Psychiatry. 2005 Jan;10(1):79-104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15289815</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioorg Med Chem. 2005 Jan 3;13(1):77-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15582454</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2005 Sep 22;353(12):1209-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16172203</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychophysiology. 2005 Sep;42(5):588-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16176381</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CNS Neurol Disord Drug Targets. 2006 Feb;5(1):25-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16613552</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuropsychopharmacology. 2006 Nov;31(11):2368-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16855531</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Gen Psychiatry. 2006 Dec;63(12):1325-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17146007</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Behav Brain Res. 2007 Aug 22;182(1):1-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17570538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Pharmacol Sci. 2007 Aug;28(8):390-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17629962</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychopharmacology (Berl). 2007 Oct;194(3):289-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17579840</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Biochem Behav. 2008 Jan;88(3):306-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17900675</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Exp Ther. 2008 Mar;324(3):1212-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18096759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychopharmacology (Berl). 2008 Aug;199(3):331-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18568339</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biol Psychiatry. 2008 Aug 1;64(3):235-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18325483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuropsychopharmacology. 2008 Oct;33(11):2648-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18075489</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Behav Pharmacol. 2008 Dec;19(8):786-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19020413</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuropharmacology. 2009 May-Jun;56(6-7):956-69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19371586</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Behav Brain Res. 2009 Dec 7;204(2):387-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19114060</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Psychiatry. 2000 Oct;157(10):1660-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11007721</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychopharmacology (Berl). 2001 Jul;156(2-3):117-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11549216</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychopharmacology (Berl). 2001 Jul;156(2-3):194-215</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11549223</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Exp Ther. 2002 Nov;303(2):791-804</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12388666</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Pharm Des. 2003;9(8):643-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12570797</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Psychiatry. 1978 May;135(5):585-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">347954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychophysiology. 1978 Jul;15(4):339-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">693742</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Neurol. 1984 Mar;41(3):271-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6582810</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
